Thermal feedback systems and methods of using the same
09833287 · 2017-12-05
Assignee
Inventors
Cpc classification
A61B18/18
HUMAN NECESSITIES
A61B5/0036
HUMAN NECESSITIES
A61B5/4836
HUMAN NECESSITIES
A61B5/743
HUMAN NECESSITIES
International classification
A61B18/18
HUMAN NECESSITIES
A61B18/12
HUMAN NECESSITIES
A61B5/00
HUMAN NECESSITIES
A61B5/01
HUMAN NECESSITIES
Abstract
A system for providing feedback during an electrosurgical procedure on a target tissue is provided. The system includes an electrosurgical energy source; an electrode probe assembly connected to the electrosurgical energy source, wherein the electrode probe assembly includes at least one electrode assembly having a needle configured to deliver electrosurgical energy to the target tissue; at least one thermal feedback assembly connected to the electrosurgical energy source, wherein each thermal feedback assembly includes at least one temperature sensor assembly; and a hub configured to selectively support the electrode probe assembly and each thermal feedback assembly such that the needle of the electrode probe assembly and each temperature sensor assembly of each thermal feedback assembly are proximate one another when disposed proximate the target tissue.
Claims
1. A system comprising: an electrosurgical generator configured to generate microwave energy; an antenna assembly configured to couple to the electrosurgical generator and deliver the generated microwave energy to tissue; a thermal feedback assembly including a plurality of temperature sensor assemblies, the thermal feedback assembly configured to measure a temperature of tissue during delivery of the generated microwave energy to tissue and transmit the measured temperature to the electrosurgical generator; and a hub configured to support the antenna assembly and the thermal feedback assembly such that the antenna assembly and each temperature sensor assembly of the thermal feedback assembly are proximate to one another when disposed proximate tissue.
2. The system according to claim 1, wherein the electrosurgical generator is further configured to control generation of microwave energy based on the measured temperature.
3. The system according to claim 1, wherein the electrosurgical generator is further configured to estimate a desired thermal treatment volume based on the measured temperature.
4. The system according to claim 1, further comprising a coolant supply fluidly coupled to the antenna assembly, the coolant supply configured to circulate a coolant fluid through the antenna assembly.
5. The system according to claim 1, wherein the thermal feedback assembly is configured to measure temperature proximate a distal portion of the antenna assembly.
6. The system according to claim 1, wherein the antenna assembly includes an inner tube configured to circulate coolant fluid therethrough.
7. The system according to claim 1, wherein the hub is configured to house a portion of the antenna assembly and circulate coolant fluid therethrough.
8. The system according to claim 1, wherein the antenna assembly includes a distal radiating portion configured to deliver the generated microwave energy.
9. The system according to claim 1, wherein the thermal feedback assembly includes at least one of a temperature sensor or a thermocouple.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) The features of the system and method of use of the system of the present disclosure will become more readily apparent and may be better understood by referring to the following detailed descriptions of illustrative embodiments of the present disclosure, taken in conjunction with the accompanying drawings, wherein:
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
DETAILED DESCRIPTION OF EMBODIMENTS
(14) The systems and methods of the present disclosure provide for a more precise controlled monitoring and/or feedback of an electrode probe during therapeutic use in a target surgical site, e.g., in a cancer tumor. Moreover, the systems and methods of the present disclosure provide for an improved ability to predict and/or estimate the depth and/or volume of treatment possible by the electrode probe when the electrode probe of an electrosurgical treatment device is set to a particular or various operative parameters.
(15) It will be readily apparent to a person skilled in the art that the systems and methods of use of the systems can be used to monitor or provide feedback during treatment of body tissues in any body cavity or tissue locations that are accessible by percutaneous or endoscopic catheters or open surgical techniques, and is not limited to cancer tumors or the like. Application of the systems and methods in any corporal organ and/or tissue is intended to be included within the scope of the present disclosure.
(16) 1. System for Thermal Feedback
(17) In the drawings and in the description which follows, the term “proximal”, as is traditional, will refer to the end of the system, or component thereof, which is closest to the operator, and the term “distal” will refer to the end of the system, or component thereof, which is more remote from the operator.
(18) With reference to
(19) At least one electrode probe assembly 300 is provided which is operatively associated with feedback assembly 200 and is connectable to electrosurgical energy source 10 in order to perform tissue ablation and the like. Each electrode probe assembly 300 may include a rigid shaft, antenna or needle 310 configured for insertion into a target tissue or organ “OR”. Needle 310 of each probe assembly 300 may terminate in an exposed distal tip 312 having a pointed configuration for facilitating percutaneous insertion of needle 310 into body organ “OR”. A portion of the external surface of needle 310 of each electrode probe assembly 300 is covered with an insulating material, as indicated by hatched line areas in
(20) Reference may be made to commonly assigned U.S. application Ser. No. 11/495,033, filed on Jul. 28, 2006, and entitled “COOL-TIP THERMOCOUPLE INCLUDING TWO-PIECE HUB” for a detailed discussion of the construction and operation of electrode probe assembly 300.
(21) Temperatures at, or near the exposed distal tip(s) 312 of needle(s) 310 may be controlled by adjusting a flow of fluid coolant through needle 310. Accordingly, the temperature of the tissue contacting at or near distal tip(s) 312 is controlled. In operation, fluid from coolant supply 30 is carried the length of needle 310 through an inner tube (not shown) extending therethrough to the distal end of needle 310 terminating in an open end or cavity (not shown) of distal tip 312. At the opposite end of needle 310, the inner tube is connected to receive fluid. Backflow from distal tip(s) 312 is through an exit port (not shown) of needle 310.
(22) Feedback system 100 may further include a reference electrode 40 that may be placed in contact with the skin of a patient or an external surface of organ “OR” with a connection 42 to electrosurgical energy source 10. Reference electrode 40 and connection 42 serve as a path for return current from electrosurgical energy source 10 through needle 310 of electrode probe assembly 300.
(23) As seen in
(24) For example, in
(25) Data processors may be connected to display devices to visualize targeted region “T” and/or ablation volume “T1” in real time during the ablation procedure.
(26) As seen in
(27) With continued reference to
(28) As seen in
(29) As seen in
(30) As seen in
(31) Each temperature sensor assembly 220 is electrically or optically connected to electrosurgical generator 10 via a suitable electrical connector or the like 230.
(32) Temperature sensors 222 include one or more of an emitter, sensor or marker to provide special relationship to electrode assembly 310. Each temperature sensor assembly 220 may include a temperature sensor 222 in the form of a rigid or semi-rigid cannula 223 and/or needles configured for insertion and/or penetration into the target surgical site. Suitable temperature sensors 222 may include thermocouples, resistive temperature devices (RTD) or fiber optic temperature probes sold under the tradename “Fluoroptic® Thermometer, available from Luxtron®, Santa Clara, Calif. Temperature sensors 222 are shown and described in U.S. Pat. Nos. 4,075,497; 4,215,275; 4,448,547; 4,560,286; 4,752,141; 4,883,354; and 4,988,212.
(33) Fluoroptic® temperature sensors 222 are configured to measure the decay time of light emitted from phosphorescent materials (e.g., phosphors). The decay time is a persistent property of the sensor that varies directly with the temperature.
(34) Other suitable temperature sensors for use with temperature sensor assemblies 220, to measure the temperature at a target surgical site, include and are not limited to optical sensors (e.g., Flouroptic®, infrared, etc.), thermocouples, Resistance-Temperature-Detectors (RTD), thermistors, MRI, fluoroscopic, ultrasound, CT and the like.
(35) Temperature sensors 222 may be configured to measure or monitor temperatures greater than about 60° C. In an embodiment, feedback system 100 may be provided with suitable algorithms or the like for interpolating temperature values from at least two temperature sensors 222 and/or for integrating thermal damage from at least two temperature sensors 222. One real-time temperature sensor may be used in conjunction with an assumed or predetermined value from a look-up table or similar method.
(36) The temperature measurements delivered to feedback system 100 may be used to generate a thermal map of the target area and/or, upon integration, may be used to account for particular tissue characteristics, such as, for example, perfusion, conduction, resistance and/or density.
(37) In an embodiment, temperature sensors 222 may be deployed around needle 310 of the electrode probe assembly 300. Such temperature sensors may be constructed of suitable shape memory alloys so as to permit the temperature sensor to wrap around needle 310. Additionally, in an embodiment, a cannula including temperature sensors may be deployed about needle 310 of the electrode probe assembly 300. In another embodiment, as seen in
(38) Electrosurgical generator 10 and electrode probe assembly 300 may be configured to deliver energy to at least one of a radiofrequency, a microwave, an ultrasound, and a cryo-therapy needle.
(39) Feedback system 100 is capable of providing size predictability for ablation volume to be created during a thermal procedure of a target region prior to the ablation volume exceeding a predetermined volume during the thermal procedure. For example, feedback system 100 may provide feedback regarding a volume of the thermal therapy (e.g., diameter), and estimation of an overall size of the volume of the thermal therapy, an estimation of a rate of growth of the volume of the thermal therapy, and/or an estimation of a time to completion of the thermal therapy. All of this information may be displayed on a monitor 54 (See
(40) As seen in
(41) As seen in
(42) As seen in
(43) Each temperature sensor 222′ or 222″ may include at least one, and as seen in
(44) As seen in
(45) Each temperature sensor 222′, 222″ may be deployable to a known and/or predetermined radial distance from respective distal tips 312′, 312″ of respective electrode probe assembly 310′, 310″. In accordance with
(46) As seen in
(47) 2. Method for Thermal Feedback
(48) With reference to
(49) A method of the present disclosure includes determining a zone of thermal treatment during and/or post treatment of the target tissue or organ “OR”. The method may comprise the step of measuring a temperature of the target tissue or organ “OR”, at known distances relative thereto, during and/or post treatment of the target tissue or organ “OR”. The temperature of the target tissue or organ “OR”, at the known distance, may be an absolute temperature and/or a temperature that is interpolated. Additionally, the method may comprise integrating the temperature over time to determine an extent of thermal treatment. Such an integration may be calculated using an “Arrhenius thermal treatment integral” or other methods of thermal damage estimation.
(50) As used herein, “thermal damage” is a term that describes a quantity representing a relative amount of destruction to a tissue component. The component of interest can vary widely between applications from sub-cellular components, such as, for example, protein or organelles, to many celled systems, such as, for example, tumors or organs. To study systems spanning such a wide range of scale different techniques may be applied. For a relatively small system, one approach may be an “ab initio” method or some other molecular dynamic approach. For relatively larger systems, one approach may be to use an empirical method, such as, for example, the “Arrhenius” method described herein or a critical temperature criterion.
(51) The term “Arrhenius thermal treatment” refers to a method of quantifying thermal effects on underlying tissue. The present method thus models microscopic effects in tissue, such as, for example, the denaturation of a single species of protein, or models macroscopic effects in tissue, such as, for example, a color change of the tissue associated with the thermal treatment where many different reactions have taken place.
(52) The equation for the “Arrhenius model” may be represented by the following equation:
(53)
(54) where:
(55) Ω=is the thermal effect sustained by the tissue or organ;
(56) c(t)=is the amount of the component of interest remaining;
(57) c(0)=is the amount of the component of interest at time zero;
(58) A=is the frequency factor, approximately 7.39×10.sup.39 l/s (specific to liver tissue); and
(59) ΔE=is the activation energy, approximately 2.577×10.sup.5 J/mol (specific to liver tissue).
(60) The “Arrhenius model” is used because, in addition to combined processes, the “Arrhenius model” applies to individual processes as well. Individual processes that may be of interest include and are not limited to the denaturation of a lipid bi-layer of a cell, the denaturation of mitochondrial proteins, and the denaturation of nuclear proteins. The denaturation of lipid bi-layer is of interest because the lipid bi-layer loses its structure before many other parts of a cell. The denaturation of mitochondrial and nuclear proteins is of interest because they denature at temperatures in the range of about 42 to 60° C.
(61) A method of the present disclosure may also include the step of using a position of electrode probe assembly 300, 300′ or 300″ and needle 310, positional temperature and/or feedback temperature received from hyperthermia feedback assembly 200 to determine the extent of thermal effect or treatment to the target tissue or organ “OR”. The position of electrode probe assembly 300, 300′ or 300″ and needle 310 may be determined using a suitable positional indicator. The positional temperature may be determined by the location of temperature sensor 222, 222′, 222″ or 222′″ and may be used to determine the presence of the lack of heat in the tissue or organ “OR”.
(62) A method of the present disclosure may also include the step of determining the spatial relationship between electrode probe assembly 300 and temperature sensor 222. Spatial relationship of electrode probe assembly 300 and temperature sensor 222 and temperature measured at temperature sensor 222 are feedback to computer 20 to determine an extent of thermal damage that may be displayed on monitor 54 or used to alter the output of electrosurgical energy source 10.
(63) A method of the present disclosure may use a three-dimensional (3D) thermal image/map to determine a dimension of thermal treatment of the target tissue of organ “OR”.
(64) According to a method of the present disclosure, computer 20 of feedback system 100 is provided with information regarding a location of the target tissue or organ “OR”, a location of critical biological structures (e.g., tissue, organs, vessels, etc.), a size and/or shape of the tumor or the target tissue or organ “OR” to be thermally treated, and a desired size of the thermal treatment volume. With this information inputted into computer 20, computer 20 may apply the “Arrhenius model” in order to develop a course of treatment.
(65) According to a method of the present disclosure, an electrode probe assembly 300, 300′ or 300″ including a particular needle 310 having a given length “L” of exposure of distal tip 312 thereof is selected for a particular thermal procedure. A length “L” of electrode exposure may be user selected based on a desired volume of tissue to be treated or diameter “W” of thermal treatment. With the particular electrode probe assembly 300, 300′ or 300″ selected the parameters (e.g., dimensions, power rating, etc.) of electrode probe assembly 300, 300′ or 300″ is manually inputted or automatically selected from a look-up table for use by the electrosurgical generator 10 and/or computer 20.
(66) With the parameters or characteristics of the tumor, target tissue or organ “OR” inputted into the electrosurgical energy source 10 and/or computer 20 and the parameters or characteristics of the electrode probe assembly 300, 300′ or 300″ selected also inputted into the electrosurgical generator 10 and/or computer 20, the parameters of the energy to be delivered to the tumor, target tissue or organ “OR”, via the electrode probe assembly 300, 300′ or 300″, are determined. As seen in
(67) With thermal feedback assembly 200 and electrode probe assembly 300 positioned, the placement of thermal feedback assembly 200 and electrode probe assembly 300 is confirmed. Next, a spatial relationship of temperature sensors 222 and electrode probe assembly 300 may be determined by using thermal feedback assembly 200 or use of other markers, and communicated to electrosurgical energy source 10 and/or computer 20 for use of feedback control of energy parameter and/or size estimation. After confirmation of the placement of thermal feedback assembly 200 and electrode probe assembly 300 the thermal treatment of the tumor, target tissue or organ “OR” may begin. The thermal treatment of the tumor, target tissue or organ “OR” includes delivering energy produced by electrosurgical generator 10 to the tumor, target tissue or organ “OR” via electrode probe assembly 300.
(68) During the thermal treatment of the tumor, target tissue or organ “OR” hyperthermia feedback assembly 200 provides feedback to electrosurgical energy source 10 and/or computer 20 in the manner described above. Treatment progress is determined by computer 20 with feedback from at least one of image scanner 5, electrosurgical energy source 10, and temperature sensors 222. Treatment progress is displayed on monitor 54. Treatment progress includes one of size estimation, rate of treatment progression, and relationship of treatment volume to target volume.
(69) While the above description contains many specific examples, these specific should not be construed as limitations on the scope of the disclosure, but merely as exemplifications of preferred embodiments thereof. Those skilled in the art will envision many other possible variations that are within the scope and spirit of the disclosure as defined by the claims appended hereto.